Amy Burroughs, Terns Pharma CEO, joins ‘Closing Bell Overtime’ to talk progress in its GLP-1 drug development.
Source link
Amy Burroughs, Terns Pharma CEO, joins ‘Closing Bell Overtime’ to talk progress in its GLP-1 drug development.
Source link